Lead the firm’s litigation representing 100+ individuals harmed by the recalled DePuy ASR hip implant. Two nationwide settlements reached thus far in the DePuy Orthopaedics, Inc, ASR Hip Implant Products Liability Litigation (MDL 2197): one in November 2013 valued at approximately $2.5 billion and another in March 2015 valued at approximately $420 million. Litigation ongoing.
Howerton v. Cargill, Inc. (D. Haw.): Representing Cargill, Incorporated in putative nationwide false-advertising class action concerning allegedly deceptive “natural” food labeling. Class settlement approved 2014.
Argued appeal upholding trial court's decision on jurisdiction and on vacating a transfer order, In re Welfare of Children of R.A.J., 769 N.W. 2d 297 (Minn. Ct. App. July 21, 2009).
Member of trial team in Charbonneau v. Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer, Inc.. Represented plaintiffs in first Mirapex products liability bellwether trial. On July 30, 2008, jury returned a verdict in favor of plaintiffs for $8,279,300, including $7.8 million in punitive damages for failing to warn of risk of compulsive behaviors, including pathological gambling, from the Parkinson's drug Mirapex.
Member of trial team in Zwayer v. Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer, Inc.. Represented plaintiffs in second Mirapex bellwether trial. Case was confidentially settled prior to closing argument.